Main > ONCOLOGY (**) > Ovarian Cancer Pt-Sensitive R *** > Treatment > ES. P. Trabectedin+
ES. P. Trabectedin+'s subsections
(*) BR Approval Date: 2010. 10.01
(*) EU Approval Date: 2009. 11.02
(*) IN Approval Date: 2010. 10.01
+Pegylated Liposomal Doxorubicin
Company
Company Licensee JP:
Company Licensee UK
Company Licensee WW (Ex. EU, JP):
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2022. 03.15
RTM (Doxorubicin)
RTM (Trabectedin)
ES. P. Trabectedin+'s products
This section has no products